Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Mertens

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Blood|August 1, 2009
Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trialThorsten Zenz, Sonja Häbe, Tina Denzel, et al.
International Journal of Cancer|October 12, 2005
Ala228 variant of trail receptor 1 affecting the ligand binding site is associated with chronic lymphocytic leukemia, mantle cell lymphoma, prostate cancer, head and neck squamous cell carcinoma and bladder cancerStephan Wolf, Daniel Mertens, Armin Pscherer, et al.
Cell Death & Disease|July 13, 2022
Hydroxylation of the NOTCH1 intracellular domain regulates Notch signaling dynamicsFrancesca Ferrante, Benedetto Daniele Giaimo, Tobias Friedrich, et al.
Blood|December 1, 2010
DNA damage-induced transcriptional program in CLL: biological and diagnostic implications for functional p53 testingJulia Mohr, Hanne Helfrich, Maxi Fuge, et al.
Blood|December 18, 2012
Telomere length in mantle cell lymphomaBilly Michael Chelliah Jebaraj, Dirk Kienle, André Lechel, et al.
Plos One|February 6, 2013
Germline allele-specific expression of DAPK1 in chronic lymphocytic leukemiaQuan-Xiang Wei, Rainer Claus, Thomas Hielscher, et al.
Blood|October 23, 2008
miR-34a as part of the resistance network in chronic lymphocytic leukemiaThorsten Zenz, Julia Mohr, Eric Eldering, et al.
Blood|December 5, 2018
<i>FBXW7</i> mutations reduce binding of NOTCH1, leading to cleaved NOTCH1 accumulation and target gene activation in CLLViola Close, William Close, Sabrina Julia Kugler, et al.
Neuropathology and Applied Neurobiology|April 22, 2018
Comprehensive microRNA expression profiling in cerebrospinal fluid distinguishes between neurological disease classesSarah Grasedieck, Medhanie Mulaw, Nadine Sperb, et al.
Blood Advances|January 20, 2023
Acquired BTK mutations associated with resistance to noncovalent BTK inhibitorsJialei Qi, Sascha Endres, Deyan Yordanov Yosifov, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Blood|August 1, 2009
Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trialThorsten Zenz, Sonja Häbe, Tina Denzel, et al.
International Journal of Cancer|October 12, 2005
Ala228 variant of trail receptor 1 affecting the ligand binding site is associated with chronic lymphocytic leukemia, mantle cell lymphoma, prostate cancer, head and neck squamous cell carcinoma and bladder cancerStephan Wolf, Daniel Mertens, Armin Pscherer, et al.
Cell Death & Disease|July 13, 2022
Hydroxylation of the NOTCH1 intracellular domain regulates Notch signaling dynamicsFrancesca Ferrante, Benedetto Daniele Giaimo, Tobias Friedrich, et al.
Blood|December 1, 2010
DNA damage-induced transcriptional program in CLL: biological and diagnostic implications for functional p53 testingJulia Mohr, Hanne Helfrich, Maxi Fuge, et al.
Blood|December 18, 2012
Telomere length in mantle cell lymphomaBilly Michael Chelliah Jebaraj, Dirk Kienle, André Lechel, et al.
Plos One|February 6, 2013
Germline allele-specific expression of DAPK1 in chronic lymphocytic leukemiaQuan-Xiang Wei, Rainer Claus, Thomas Hielscher, et al.
Blood|October 23, 2008
miR-34a as part of the resistance network in chronic lymphocytic leukemiaThorsten Zenz, Julia Mohr, Eric Eldering, et al.
Blood|December 5, 2018
<i>FBXW7</i> mutations reduce binding of NOTCH1, leading to cleaved NOTCH1 accumulation and target gene activation in CLLViola Close, William Close, Sabrina Julia Kugler, et al.
Neuropathology and Applied Neurobiology|April 22, 2018
Comprehensive microRNA expression profiling in cerebrospinal fluid distinguishes between neurological disease classesSarah Grasedieck, Medhanie Mulaw, Nadine Sperb, et al.
Blood Advances|January 20, 2023
Acquired BTK mutations associated with resistance to noncovalent BTK inhibitorsJialei Qi, Sascha Endres, Deyan Yordanov Yosifov, et al.
Pageof 10